[thewhitetulip]

It just did. The patent expired on March 20 in India.

There are 10+ firms vying ro bring a generic glp1 anywhere the patent has expired. How effective these generics will be is yet to be seen.

This might cause a lot of problems because some people are taking glp1 for "my wedding is in 1 month and I gotta reduce 10kg by then"

[tmottabr]

In Brasil the patent also expired on March 20, and already there are a dozen of generics that have already applied to get approval, but none got it so far.

So Novo Nordisk itself droped the price a LOT in the last weeks, and even after the price drop you can get the first month free at a lower dosage when starting with a higher one.. Like if you got the 5ml prescripted to you would they send firs month of the 2.5ml for free..

Even the propspect of having generics in the market is already making the price drop..

[thewhitetulip]

In India they (novodisk and other patent holders) have ruled out price reduction.

But I suppose they also have to reduce price some or the other day.

In India a few glp1 drugs are launching tomorrow. So I think they already got approval